<DOC>
	<DOCNO>NCT02847702</DOCNO>
	<brief_summary>The purpose study evaluate analgesic efficacy , safety , tolerability VM902A twice daily compare placebo subject moderate severe chronic pain due OA knee .</brief_summary>
	<brief_title>A Study Evaluate Analgesic Efficacy Safety VM902A Subjects With Osteoarthritis ( OA ) Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Analgesics</mesh_term>
	<criteria>Key Inclusion Criteria Include : 1 . Males females ≥ 40 ≤ 75 year age moderate severe chronic OA pain knee ( lasting several hour daily ) predominant pain condition least 6 month prior screen 2 . Diagnostic criterion primary pain condition ( American College Rheumatology [ ACR ] clinical radiographic criterion ) : At least 1 follow addition knee pain : age &gt; 50 , stiffness &lt; 30 min , crepitus active motion , KellgrenLawrence ( KL ) grade 2 3 radiographic evidence screen visit determine local radiologist rheumatologist . Note KL grade 2 3 require presence osteophyte , require meet ACR clinical radiographic criterion knee OA 3 . Subjects whose OA pain index knee adequately treat prior screen visit : • Subjects must selfreported average pain intensity rating moderate severe verbal rating scale ( ie , none , mild , moderate , severe ) 7 day prior screen visit 4 . The subject must `` average pain last 24 hour '' score ≥ 5 ≤ 9 11point numerical rating scale ( NRS ) index knee ≥ 3 consecutive day screen period come randomization within 72 hour qualification meet 5 . Subjects willing able stop take any/all analgesic medication , include overthecounter pain medication , opioids , marijuana , topical analgesic OA pain duration treatment period , exception studyspecific rescue medication . Key Exclusion Criteria Include : 1 . Subjects radiographic evidence OA KL grade 0 , 1 , 4 2 . Subjects risk destructive arthropathy , subject history osteonecrosis , osteoporotic fracture , rapidly progressive osteoarthritis ( RPOA 1 2 ) , subchondral insufficiency fracture , hip/knee dislocation 3 . Subjects consider high risk surgery base upon American Society Anesthesiologists physical classification system surgery grading , subject would willing undergo joint replacement surgery require 4 . Subjects chronic pain condition OA knee predominant pain condition , include gout ( except subject gout control diet and/or stable suppressive treatment uric acid reduce medication ( ) and/or colchicine , attack within past 2 year ) , pseudogout , psoriatic arthritis , active Lyme disease , rheumatoid arthritis inflammatory arthritis , fibromyalgia , neuropathic pain condition , bursitis , acute injury sign active infection target pain area 5 . Subjects schedule surgical intervention disease site major surgery study conduct period 6 . Subjects history prior joint replacement index knee 7 . Subjects arthroscopy either knee hip within 6 month enter study , open surgery either knee hip within 12 month enter study . Other protocolspecific inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Pain</keyword>
	<keyword>Osteoarthritis , knee</keyword>
</DOC>